AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
OraSure Launches HEMAcollect PROTEIN Blood Collection Tube for Proteomic Research.
ByAinvest
Thursday, Jul 10, 2025 7:09 am ET1min read
OraSure Technologies has launched HEMAcollect●PROTEIN, an evacuated blood collection tube designed to preserve and stabilize plasma proteins in whole blood for up to seven days. The product is intended for research use only and is expected to provide operational and financial efficiencies for proteomic researchers while supporting the generation of high-quality data. The HEMAcollect●PROTEIN BCT can be stored and transported at ambient temperature, addressing limitations of general blood collection tubes.
OraSure Technologies, Inc. (NASDAQ: OSUR) has introduced a novel blood collection device, HEMAcollect●PROTEIN, designed to address the challenges faced by proteomic researchers. The device, developed by the company's subsidiary DNA Genotek, is an evacuated blood collection tube (BCT) that can preserve and stabilize plasma proteins in whole blood for up to seven days at ambient temperature [1].The HEMAcollect●PROTEIN BCT is powered by ProteoPrecision™ technology, which minimizes hemolysis and platelet activation, ensuring the sample accurately reflects the body's state at the time of collection. This innovation addresses the limitations of general blood collection tubes, which often require refrigeration and have shorter stabilization periods [1].
The device is compatible with a broad range of proteomic technologies, including mass spectrometry, immunoassays, and high-throughput affinity-based platforms. This versatility makes it suitable for various research applications, such as oncology, neurology, cardiology, and metabolic disorders [1].
OraSure Technologies anticipates that the HEMAcollect●PROTEIN BCT will deliver operational and financial efficiencies for proteomic researchers. The ability to store and transport samples at ambient temperature simplifies workflows and reduces the need for specialized refrigeration equipment [1].
The launch of the HEMAcollect●PROTEIN BCT is part of OraSure Technologies' commitment to enhancing the quality of insights for researchers through innovative sample management solutions [1].
References:
[1] https://www.globenewswire.com/news-release/2025/07/10/3113127/11732/en/OraSure-Launches-Novel-Blood-Collection-Device-for-Proteomic-Research.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet